Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer [Phase 2]
Phase 2 trial update evaluating Cu64-DOTA-trastuzumab PET imaging and biomarkers to predict response to neoadjuvant trastuzumab plus pertuzu…
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: Efficacy of Metformin as Preventive Treatment in Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients [Phase 2]
A Phase 2 trial investigated metformin as preventive treatment for paclitaxel-induced peripheral neuropathy in breast cancer patients; the s…
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Immunological Variables Associated to ICI Toxicity in Cancer Patients [Phase 2]
A Phase 2 clinical trial investigating immunological variables associated with immune checkpoint inhibitor toxicity in cancer patients.
-
CLINICAL_TRIALS trial_result · 2023-03-07Clinical Trial Update: Pyrotinib, Dalpiciclib(SHR6390) and Endocrine Therapy in Subjects With Dual-receptor Positive(ER+/HER2+) Advanced Breast Cancer [Phase 1, Phase 2]
Phase 1/2 trial update evaluating pyrotinib, dalpiciclib (SHR6390), and endocrine therapy in ER+/HER2+ advanced breast cancer. Status unknow…
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients [Phase 1, Phase 2]
Phase 1/2 trial evaluating neoadjuvant chemotherapy with Myocet, Taxotere, and Herceptin for HER2-positive breast cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer [Phase 3]
Phase 3 trial update evaluating fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel in early breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients [Phase 2]
Phase 2 trial comparing exemestane to anastrozole as first-line hormone therapy in postmenopausal metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients [Phase 2]
Phase 2 trial evaluating neoadjuvant Gemcitabine, Doxorubicin, and Paclitaxel (GAT) in breast cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling [Phase 2]
Phase 2 trial investigating neoadjuvant chemotherapy with trastuzumab and pertuzumab in HER2-negative breast cancer patients with abnormal H…
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound) [Phase 3]
A Phase 3 trial evaluating SYHX2011 versus paclitaxel for advanced breast cancer is ongoing, with no current status reported.
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: TAC Versus TC for Adjuvant Breast Cancer [Phase 3]
A Phase 3 trial comparing TAC versus TC for adjuvant breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: Neoadjuvant Inetetamab Combined With Pertuzumab and Paclitaxel/Carboplatin for Breast Cancer [Phase 2]
Phase 2 trial update for neoadjuvant Inetetamab with pertuzumab and paclitaxel/carboplatin in locally advanced breast cancer is reported, wi…
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: Chidamide Plus PD-1 Plus Paclitaxel of Neoadjuvant Treatment in Low HR Expression,HER2-negative Early Breast Cancer. [Phase 2]
A Phase 2 clinical trial update on neoadjuvant treatment for low HR expression, HER2-negative early breast cancer combining chidamide, PD-1 …
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: Letrozole Plus Metronomic Capecitabine as First-line Treatment for Patients With Recurrent or Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating letrozole plus metronomic capecitabine as first-line therapy for recurrent or metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer [Phase 2]
Phase 2 trial exploring oral vinorelbine plus capecitabine in advanced HER2-negative breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Chidamide in Combination With Vincristine Metronomic Chemotherapy for Advanced Triple-negative Breast Cancer [Phase 1, Phase 2]
A clinical trial update for chidamide in combination with vincristine metronomic chemotherapy in advanced triple-negative breast cancer, cur…
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors [Phase 1]
Phase 1 trial update on an arginase-1 peptide vaccine in patients with metastatic solid tumors, including non-small cell lung cancer and uro…
-
CLINICAL_TRIALS trial_result · 2023-02-27Clinical Trial Update: Clinical Trial to Assess Efficacy and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients [Phase 3]
Phase 3 trial update evaluating trastuzumab (NNG-TMAB) for recurrent or metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy [Phase 2]
Phase 2 trial update for an injection regimen of PEG-rhG-CSF during chemotherapy in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines [Phase 3]
Phase 3 trial evaluating nebivolol for cardioprotective effects during anthracycline chemotherapy in cancer patients.
-
CLINICAL_TRIALS trial_result · 2023-02-22Clinical Trial Update: Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy [Phase 2]
Phase 2 clinical trial evaluating transdermal or oral telapristone acetate in patients undergoing mastectomy; trial completed with results p…
-
CLINICAL_TRIALS trial_result · 2023-02-22Clinical Trial Update: Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer Patients [Phase 2]
Phase 2 clinical trial update on dual sentinel lymph node staining in breast cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-22Clinical Trial Update: Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer [NA]
A clinical trial evaluating dedicated breast PET/MRI for assessing disease extent in women with newly diagnosed breast cancer has been termi…
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy [Phase 2]
Phase 2 clinical trial update describing the use of serial FES PET/CT imaging to assess estrogen receptor expression in patients with estrog…
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer [Phase 3]
A Phase 3 trial evaluating different durations of adjuvant anastrozole therapy after 2 to 3 years of tamoxifen in breast cancer patients.